Roche Holding AG (RHHBY)
OTCMKTS
· Delayed Price · Currency is USD
41.22
-0.71 (-1.68%)
Mar 31, 2025, 1:13 PM EST
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B CHF
Revenue Growth
+3.23%
P/S Ratio
n/a
Revenue / Employee
604.32K CHF
Employees
103,249
Market Cap
269.86B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 16.04M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| American Oncology Network | 1.76B |
Roche Holding AG News
- 4 hours ago - These 16 dividend stocks have ‘high quality yields' if you want to diversify away from the U.S. - Market Watch
- 6 days ago - Roche Annual General Meeting 2025 - GlobeNewsWire
- 12 days ago - Roche abandons global diversity targets on concern over U.S. executive orders - Reuters
- 12 days ago - Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer - GlobeNewsWire
- 12 days ago - Roche Holding Has A Canadian Depositary Receipt - Seeking Alpha
- 13 days ago - Sarepta plunges after death linked to Elevidys - Seeking Alpha
- 14 days ago - Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference - GlobeNewsWire
- 15 days ago - Notable healthcare headlines for the week: Merck, Novo Nordisk, J&J and Roche in focus - Seeking Alpha